Generic Name and Formulations:
Prednisolone acetate 0.5%, neomycin (as sulfate) 0.35%, polymyxin B sulfate 10000 Units; per mL; oph. susp.
Indications for POLY-PRED:
Ocular inflammation associated with infection.
Adults and Children:
To treat eyes: 1–2 drops every 3–4 hrs, or more often if necessary. To treat lids: 1–2 drops every 3–4 hrs and rub excess around lids; max 20mL per therapeutic course.
Fungal, viral or mycobacterial infections. Uncomplicated removal of foreign body.
Corneal or scleral thinning. Glaucoma. Myopia. Diabetes. Monitor for secondary infections and intraocular pressure in prolonged use. Avoid abrupt cessation. Infants and young children. Pregnancy.
Steroid + antibiotics.
Increased intraocular pressure, cataracts, corneal perforation, optic nerve damage. May mask signs of infection. Allergic dermatitis.
Endocrinology Advisor Articles
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood
- Early Treatment Intensification and Faster Glycemic Control in T2D
- Comparing Antidiabetic Drug Classes for Risk of Heart Failure
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- Cochrane Data Release and the Case for "Open Science"
- Rate of Type 2 Diabetes in Chronic Kidney Disease
- Characteristics of Acquired Partial Lipodystrophy With Metabolic Abnormalities
- Poor Glycemic Control Associated With Higher Risk for Dementia in Older Adults With T1D
- Shift Seen From EDs to Urgent Care for Low-Acuity, Acute Care